Skip to main content
. 2011 Apr 22;34(Suppl 2):S279–S284. doi: 10.2337/dc11-s231

Figure 1.

Figure 1

Change in A1C with long-acting GLP-1 receptor agonists across the clinical trials (24,32,36–39,41). *P < 0.01 vs. comparator; **P < 0.001; ***P < 0.0001; ###P < 0.0001 vs. placebo.